A New Signaling Pathway for HCV Inhibition by Estrogen: GPR30 Activation Leads to Cleavage of Occludin by MMP-9. [electronic resource]
Producer: 20160719Description: e0145212 p. digitalISSN:- 1932-6203
- Carcinoma, Hepatocellular -- metabolism
- Cell Line, Tumor
- Cyclopentanes -- pharmacology
- Estrogen Antagonists -- pharmacology
- Estrogens -- pharmacology
- Hepacivirus -- drug effects
- Host-Pathogen Interactions -- drug effects
- Humans
- Immunoblotting
- Liver Neoplasms -- metabolism
- MCF-7 Cells
- Matrix Metalloproteinase 9 -- genetics
- Matrix Metalloproteinase Inhibitors -- pharmacology
- Occludin -- metabolism
- Phenyl Ethers -- pharmacology
- Proteolysis -- drug effects
- Quinolines -- pharmacology
- RNA Interference
- RNA, Viral -- genetics
- Receptors, Estrogen -- antagonists & inhibitors
- Receptors, G-Protein-Coupled -- agonists
- Reverse Transcriptase Polymerase Chain Reaction
- Signal Transduction -- drug effects
- Tamoxifen -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.